Literature DB >> 30554391

Gut microbiome approaches to treat obesity in humans.

Fernanda Bianchi1, Ana Luiza Rocha Faria Duque1, Susana Marta Isay Saad2,3, Katia Sivieri4.   

Abstract

The rising worldwide prevalence of obesity has become a major concern having many implications for the public health and the economy. It is well known that many factors such as lifestyle, increased intake of foods high in fat and sugar and a host's genetic profile can lead to obesity. Besides these factors, recent studies have pointed to the gut microbiota composition as being responsible for the development of obesity. Since then, many efforts have been made to understand the link between the gut microbiota composition and obesity, as well as the role of food ingredients, such as pro- and prebiotics, in the modulation of the gut microbiota. Studies involving the gut microbiota composition of obese individuals are however still controversial, making it difficult to treat obesity. In this sense, this mini-review deals with obesity and the relationship with gut microbiota, summarising the principal findings on gut microbiome approaches for treating obesity in humans.

Entities:  

Keywords:  Gut microbiota; Management of obesity; Obesity

Mesh:

Substances:

Year:  2018        PMID: 30554391     DOI: 10.1007/s00253-018-9570-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Beneficial effects of mung bean seed coat on the prevention of high-fat diet-induced obesity and the modulation of gut microbiota in mice.

Authors:  Dianzhi Hou; Qingyu Zhao; Laraib Yousaf; Yong Xue; Qun Shen
Journal:  Eur J Nutr       Date:  2020-10-01       Impact factor: 5.614

2.  Undaria pinnatifida improves obesity-related outcomes in association with gut microbiota and metabolomics modulation in high-fat diet-fed mice.

Authors:  Lili Li; Yuting Wang; Jingyi Yuan; Zhengyi Liu; Changqing Ye; Song Qin
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-19       Impact factor: 4.813

3.  Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort.

Authors:  Kui Deng; Menglei Shuai; Zheqing Zhang; Zengliang Jiang; Yuanqing Fu; Luqi Shen; Ju-Sheng Zheng; Yu-Ming Chen
Journal:  BMC Med       Date:  2022-05-19       Impact factor: 11.150

4.  A Pilot Study on the Metabolic Impact of Mediterranean Diet in Type 2 Diabetes: Is Gut Microbiota the Key?

Authors:  Shámila Ismael; Marta P Silvestre; Miguel Vasques; João R Araújo; Juliana Morais; Maria Inês Duarte; Diogo Pestana; Ana Faria; José B Pereira-Leal; Joana Vaz; Pedro Ribeiro; Diana Teixeira; Cláudia Marques; Conceição Calhau
Journal:  Nutrients       Date:  2021-04-08       Impact factor: 5.717

Review 5.  Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases.

Authors:  Carolina Battistini; Rafael Ballan; Marcos Edgar Herkenhoff; Susana Marta Isay Saad; Jun Sun
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

6.  In Vitro Fecal Fermentation Patterns of Arabinoxylan from Rice Bran on Fecal Microbiota from Normal-Weight and Overweight/Obese Subjects.

Authors:  Inah Gu; Wing Shun Lam; Daya Marasini; Cindi Brownmiller; Brett J Savary; Jung Ae Lee; Franck Carbonero; Sun-Ok Lee
Journal:  Nutrients       Date:  2021-06-15       Impact factor: 5.717

7.  Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals.

Authors:  Roque Pastor-Ibáñez; Juan Blanco-Heredia; Florencia Etcheverry; Sonsoles Sánchez-Palomino; Francisco Díez-Fuertes; Rosa Casas; María Ángeles Navarrete-Muñoz; Sara Castro-Barquero; Constanza Lucero; Irene Fernández; Lorna Leal; José Miguel Benito; Marc Noguera-Julian; Roger Paredes; Norma Rallón; Ramón Estruch; David Torrents; Felipe García
Journal:  Nutrients       Date:  2021-03-30       Impact factor: 5.717

8.  Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model.

Authors:  Yoichiro Kashiwagi; Shunsuke Aburaya; Naoyuki Sugiyama; Yuki Narukawa; Yuta Sakamoto; Masatomo Takahashi; Hayato Uemura; Rentaro Yamashita; Shotaro Tominaga; Satoko Hayashi; Takenori Nozaki; Satoru Yamada; Yoshihiro Izumi; Atsunori Kashiwagi; Takeshi Bamba; Yasushi Ishihama; Shinya Murakami
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.